Treatment of Hepatic Encephalopathy: Comparing the Effects of Adding Rifaximin to Lactulose on Patient Outcomes

被引:0
|
作者
Courson, Alesa [1 ]
Twilla, Jennifer D. [1 ]
Hara, Jayme [1 ]
Jones, G. Morgan [1 ]
机构
[1] Methodist Univ Hosp, Memphis, TN USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1378
引用
收藏
页码:878A / 878A
页数:1
相关论文
共 50 条
  • [1] OUTCOMES OF RIFAXIMIN PLUS LACTULOSE VERSUS LACTULOSE ALONE IN TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY
    Gill, M. L.
    Niaz, T.
    Aziz, H.
    Khan, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S215 - S215
  • [2] Hepatic Encephalopathy Treatment: Beyond Lactulose and Rifaximin
    Pronesti, Vincent
    Babich, Michael
    PRACTICAL GASTROENTEROLOGY, 2022, 46 (04) : 14 - 31
  • [3] Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy
    Kowdley, Kris V.
    Burman, Blaire E.
    ANNALS OF INTERNAL MEDICINE, 2013, 159 (08)
  • [4] A double blind randomised controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of hepatic encephalopathy
    Lunia, Manish Kumar
    Sharma, Praveen
    Sharma, Brijesh Chander
    Sarin, Shiv Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 52 - 52
  • [5] Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy
    Neff, G. W.
    Kemmer, N.
    Zacharias, V. C.
    Kaiser, T.
    Duncan, C.
    McHenry, R.
    Jonas, M.
    Novick, D.
    Williamson, C.
    Hess, K.
    Thomas, M.
    Buell, J.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) : 3552 - 3555
  • [6] Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy
    Moon, Andrew M. M.
    Kim, Hannah P. P.
    Jiang, Yue
    Lupu, Gabriel
    Bissram, Jennifer S. S.
    Barritt, A. Sidney
    Tapper, Elliot B. B.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (02): : 284 - 293
  • [7] Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy
    Sidhu, Sandeep S.
    Goyal, Omesh
    Parker, Richard A.
    Kishore, Harsh
    Sood, Ajit
    LIVER INTERNATIONAL, 2016, 36 (03) : 378 - 385
  • [8] The clinical efficacy of rifaximin in the treatment or hepatic encephalopathy (comparison with lactulose).
    Song, KH
    Lee, KS
    Kim, MH
    Paik, YH
    Moon, BS
    Yoon, SH
    Han, KH
    Chon, CY
    Moon, YM
    HEPATOLOGY, 2000, 32 (04) : 407A - 407A
  • [9] Lactulose and Rifaximin as Prevention for Recurrence Hepatic Encephalopathy
    Marsigit, J.
    Maulahela, H.
    ADVANCED SCIENCE LETTERS, 2018, 24 (08) : 6186 - 6189
  • [10] Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota
    Wang, Ming-Wei
    Ma, Wei-Juan
    Wang, Yan
    Ma, Xiao-Han
    Xue, Yu-Feng
    Guan, Jing
    Chen, Xi
    FRONTIERS IN MICROBIOLOGY, 2023, 14